In this remote episode of Catawba Talks, we chat about the adjustments made by our team and how we’ve successfully grown during the challenge of COVID-19. Sit down with us to hear updates on recently awarded trials, new indications, and our overall push forward!
Shannon Weatherly and Zaidoon A. Al-Zubaidy
Join us as we explore how our CRO has adjusted to keep its team safe and still overdeliver for our clients during the COVID-19 pandemic. Of course, we do so remotely! Check-in with your Catawba Research team and hear our approach to the whole quarantine situation.
Zaidoon A. Al-Zubaidy and Shannon Weatherly
In this episode, we chat remotely with Catawba Research’s Director of Quality Assurance Kelly Field about how the FDA is handling clinical trials during the COVID-19 pandemic. Kelly breaks down the new FDA guidance, discussing how it addresses subject safety, compliance with GCP and other areas during this time of stay-at-home restrictions.
Shannon Weatherly, Kelly Field and Zaidoon A. Al-Zubaidy
On this episode, we talk with one of Catawba Research’s amazing CRAs, Loren Guzman. Listen as we chat about life on the road, how she tackles site audits with tact, why she’s known as the “Query Queen,” and how her work helps steer the success of our clinical trials.
Zaidoon A. Al-Zubaidy, Shannon Weatherly and Loren Guzman
Chris Driskill, a Catawba Research Project Manager, joins us to offer some high-level insights on one of our larger trials to date. Chris dives into his notes – and tiny handwriting – to shed light on the rosacea study, which spanned some 33 sites and included 1,116 patients. Hear Chris discuss how the team covered a lot of trial ground to knock out a roughly nine-month turnaround!
Zaidoon A. Al-Zubaidy, Chris Driskill and Shannon Weatherly
Listen as we discuss Catawba Research’s focus on 505(b)(2) clinical trials. With this accelerated trial pathway comes many benefits not just for sponsors, but for those needing these medications now. Join us in this episode as we map out our adventures in the 505(b)(2) equation for 2020 and ahead.
Zaidoon A. Al-Zubaidy and Shannon Weatherly
On this episode of Catawba Talks, we take a closer look at our past trial accomplishments. With over ten FDA approvals so far, the Catawba Research team agrees, this is just the beginning! Join us as we discuss how we’re tracking and explore our continued efforts to move into new trial spaces, such as ophthalmology. Sit back and stay tuned!
Zaidoon A. Al-Zubaidy and Shannon Weatherly
The Catawba Research team spends a lot of time with each other, collaborating on best strategies to move trials to successful completion. We’re a family as much as we are a group of dedicated, clinical research experts. However, our passion for perfection isn’t always as harmonious as it may seem! Zaidoon and Shannon open the curtain on the fire that is Catawba Research’s collective personality, explaining how their individual differences often bring them closer together.
Zaidoon A. Al-Zubaidy and Shannon Weatherly
Catawba Research works with a select group of sites to assure successful trial implementation. In this episode of Catawba Talks, we chat with Dr. Gregory Samano – one of Catawba Reseach’s “usual suspects.” Dr. Samano works with our CRO team quite a bit. Listen as he discusses why certain physicians choose to head down the pathway of clinical trial research.
Zaidoon A. Al-Zubaidy, Shannon Weatherly, & Dr. Gregory Samano
In this episode of Catawba Talks, we discuss executing trials in locations which are more difficult for a multitude of reasons, as well as indications where the patient population is harder to find and enroll. Allan Shepard, one of Catawba Research’s project managers, joins the conversation to share his experience in successfully navigating geographical nuances in regulatory issues, shipping IP, patient populations and language barriers.
Zaidoon A. Al-Zubaidy, Shannon Weatherly, & Allan Shepard
